Last reviewed · How we verify
ACH-0145228: Immediate Release — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
ACH-0145228: Immediate Release (ACH-0145228: Immediate Release) — Alexion Pharmaceuticals, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ACH-0145228: Immediate Release TARGET | ACH-0145228: Immediate Release | Alexion Pharmaceuticals, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ACH-0145228: Immediate Release CI watch — RSS
- ACH-0145228: Immediate Release CI watch — Atom
- ACH-0145228: Immediate Release CI watch — JSON
- ACH-0145228: Immediate Release alone — RSS
Cite this brief
Drug Landscape (2026). ACH-0145228: Immediate Release — Competitive Intelligence Brief. https://druglandscape.com/ci/ach-0145228-immediate-release. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing